09/05/2024 10:50 AM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 10:53 AM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 3:40 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024 1:48 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 3:28 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024 1:07 PM | Sanders Corazon D. (0001796536) (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 1:22 PM | Sanders Corazon D. (0001796536) (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/20/2024 1:23 PM | Ray Amrit (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 1:24 PM | NARACHI MICHAEL (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 1:25 PM | Ultragenyx Pharmaceutical (Issuer) WELCH DANIEL G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 1:26 PM | Fust Matthew K (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 1:29 PM | Dunsire Deborah (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 1:22 PM | SULIMAN SHEHNAAZ (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 5:31 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2024 4:11 PM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
06/12/2024 6:47 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 4:10 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024 4:20 PM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
06/10/2024 6:58 PM | Sanders Corazon D. (0001796536) (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 4:20 PM | Sanders Corazon D. (0001796536) (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2024 2:23 PM | Crombez Eric (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 3:35 PM | Crombez Eric (Reporting) Ultragenyx Pharmaceutical (Issuer) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/18/2024 5:06 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2024 7:07 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2024 12:41 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:39 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 11:54 AM | Fust Matthew K (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:13 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:15 PM | Pinion John Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:17 PM | Huang Dennis Karl (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:19 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:22 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:23 PM | Horn Howard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:06 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:08 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 7:10 PM | Crombez Eric (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:46 AM | RTW INVESTMENTS, LP (Filed by) Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
02/13/2024 2:41 PM | SANDS CAPITAL MANAGEMENT, LLC (Filed by) Ultragenyx Pharmaceutical (Subject)
| Form SC 13G | |
02/08/2024 2:49 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 9:18 AM | Ultragenyx Pharmaceutical (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/29/2024 2:26 PM | BlackRock Inc. (Filed by) Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9318&Placement=NativeDisplay&Source=NativeDisplay) Click here to see a unique election-year trade |
01/08/2024 5:03 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:17 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2023 4:22 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2023 4:14 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2023 3:47 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2023 5:31 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/20/2023 5:31 AM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
10/19/2023 3:45 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2023 6:49 PM | Ultragenyx Pharmaceutical (Subject)
| Form FWP | |
10/17/2023 3:13 PM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
10/16/2023 7:05 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2023 11:48 AM | Horn Howard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/10/2023 11:50 AM | Horn Howard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 1:15 PM | Crombez Eric (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 1:16 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 12:33 PM | Ultragenyx Pharmaceutical (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
09/11/2023 12:52 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/08/2023 7:00 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 4:01 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |